Osteoporosis Trial, Recruiting NCT07242612 Sponsor: Khyber Medical University Peshawar Condition: Osteoporosis
Back to Osteoporosis

Osteoporosis Trial, Recruiting

NCT07242612
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women who have gone through menopause and have not had a menstrual period for at least one year
  • Women who are older than 50 years of age
  • People who have been diagnosed with primary osteoporosis (bone loss not caused by another condition or medication)
  • People who are not currently taking any medications prescribed to treat osteoporosis
  • People who are not currently taking calcium or vitamin D supplements
  • People who are willing to take part and have agreed to give their formal consent to participate

Who may not be able to join:

  • Women who have had multiple broken vertebrae (bones in the spine) or who have significant wear and tear changes in the lower spine
  • People who have used certain bone or hormone-related medications in the past 18 months, including hormone or estrogen therapy, calcitonin, bisphosphonate tablets, certain intravenous (IV) bone medications, denosumab, or teriparatide
  • People who have used corticosteroid medications, either briefly or over a long period of time
  • People with a history of overactive or underactive thyroid, liver disease, kidney disease, or tumours
  • People whose osteoporosis is caused by another underlying condition, such as an eating disorder, coeliac disease, diabetes, or a blood disorder

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Asma Mehmood, PhD Scholar, Institute of Basic Medical Sciences, Khyber Medical University

Phone: 0333-9400179

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Khyber Medical University Peshawar
Registry
ClinicalTrials.gov
Start date
1 October 2025
Est. completion
25 March 2026

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Change in Bone Turnover Markers (BTMs); Change in Bone Mineral Density (BMD)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov